ArticleFrontiers in oncology2026

Utilization of immunotherapy as a neoadjuvant treatment in liver transplant recipients with hepatobiliary carcinoma.

Maen Abdelrahim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.